PROVIDER PROFILE · NPI 1326233040

Yogini MavaniDO

MEDICARE UTILIZATION · PART B · 2024
No data available for this provider in 2024.
PRESCRIBING · PART D · 2024
Total Rx claims
18
Beneficiaries
—
Total drug cost
$395
Distinct drugs
1
Brand share
0.0%
Top prescribed drugs
Gabapentin18 claims
QUALITY · MIPS · 2024
Final MIPS score
90.7
Quality
78.0
Cost
65.1
Improvement activities
40.0
Promoting interop.
0.0
Payment adjustment
0.66%
Group
FACILITY AFFILIATIONS

Hospital & Facility Affiliations (2)

Nursing home
Nursing home